Use of drugs in pregnant canine

Physiological changes during pregnancy induce profound alterations in the pharmacokinetic pro­perties of many drugs. These changes affect the distribution, absorption, metabolism, and excretion of drugs and therefore may affect their pharmacodynamic properties. An understanding of both the physiolog...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Landoni, M. F.
Formato: Artículo revista
Lenguaje:Español
Publicado: Universidad Nacional del Nordeste 2023
Materias:
Acceso en línea:https://revistas.unne.edu.ar/index.php/vet/article/view/6613
Aporte de:
Descripción
Sumario:Physiological changes during pregnancy induce profound alterations in the pharmacokinetic pro­perties of many drugs. These changes affect the distribution, absorption, metabolism, and excretion of drugs and therefore may affect their pharmacodynamic properties. An understanding of both the physiology of pregnancy and the specific pharmacology of the different agents is necessary to achieve effective treatment and limit maternal and fetal risk. Unfortunately, most drug studies exclude pregnant females, even when there are pathological entities that need to be treated during pregnancy (pain, infectious processes, etc). This review begins with a reminder of the basic concepts of pharmacokinetics and their clinical relevance. Physiological changes in pregnancy and their consequences on the pharmacokinetic and pharmacodynamic properties of many drugs are described. As a closure, the therapeutic categories most commonly indicated in pregnant females are discussed.